On‑Demand: Practical Strategies for Keeping Complex Pipelines Moving in Today’s Challenging Operating Environment

In this executive discussion, two industry leaders examine the evolving world of pharmaceutical engineering, focusing on the transition from traditional chemical structures to intricate drug molecules. They highlight how modern treatments, such as oral peptides, demand sophisticated design strategies to overcome significant manufacturing and biological hurdles. To navigate this shifting landscape, development teams must prioritize integrated problem-solving and high-quality data collection during the earliest stages of research. The dialogue emphasizes that successful commercialization now relies on balancing rapid timelines with rigorous risk management. Ultimately, the source outlines the critical methodologies required to transform complex discovery assets into viable clinical therapies.

Here are three intriguing questions addressed in the webinar:

1. How is the pharmaceutical industry evolving beyond the traditional "rule of five" to successfully deliver complex medicines such as oral GLP-1s, peptides, and PROTACs?

2. What unique engineering hurdles must be overcome through integrated drug product design to transform advanced discovery molecules into viable clinical assets?,

3. How can development teams effectively balance the intense pressure to hit rapid milestones with the necessity of generating high-quality data and managing execution risks during manufacturing scale-up?

In addition to this session, you'll be able to watch leaders across biotech, pharma, and the broader development ecosystem share practical, real-world strategies for keeping complex pipelines moving in today’s challenging funding and operating environment.

‍

PRESENTED BY:

Dan Smithey, PhD

President & CEO

Kurt R. Nielsen, PhD

Managing Partner, Expert Insights Consulting, LLC

‍

Watch Now!

‍